RenovoRx CFO James Ahlers resigns; VP Kocak named Principal Accounting Officer with $235K salary

RenovoRx, Inc.

James Ahlers resigned as CFO effective Feb 5, 2024, for personal reasons; no disagreement with the company.
Ronald B. Kocak, previously VP and Controller, appointed VP, Controller and Principal Accounting Officer effective Feb 9, 2024.
Kocak receives $235,000 base salary, up to 35% bonus, and option for 15,000 shares at $1.56, vesting over 4 years with double trigger.
Kocak will serve as principal financial and accounting officer; CFO position remains unfilled.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ronald B. Kocak

Vice President, Controller and Principal Accounting Officer

RNXT · RenovoRx, Inc.

Effective: 2024-02-09
Filed: February 9, 2024, 6:59 PM ET

On February 8, 2024, the Company’s board of directors (the “Board”), at the recommendation of the audit and compensation committees of the Board, appointed Ronald B. Kocak, CPA, CGMA, the Company’s current Vice President and Controller, to the position of Vice President, Controller and Principal Accounting Officer.

Departed

James Ahlers

Chief Financial Officer

RNXT · RenovoRx, Inc.

Effective: 2024-02-05
Filed: February 9, 2024, 6:59 PM ET

On February 5, 2024, James Ahlers provided written notice to RenovoRx, Inc. (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald B. Kocak was appointed as Vice President, Controller and Principal Accounting Officer at RenovoRx, Inc..

Action: appointed
Role: Vice President, Controller and Principal Accounting Officer

Exact text from the filing

On February 8, 2024, the Company’s board of directors (the “Board”), at the recommendation of the audit and compensation committees of the Board, appointed Ronald B. Kocak, CPA, CGMA, the Company’s current Vice President and Controller, to the position of Vice President, Controller and Principal Accounting Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James Ahlers resigned as Chief Financial Officer at RenovoRx, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On February 5, 2024, James Ahlers provided written notice to RenovoRx, Inc. (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective immediately.

View on SEC.gov

RenovoRx, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-005711

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.